Le Lézard
Classified in: Health, Covid-19 virus
Subjects: NEW PRODUCTS/SERVICES, CALENDAR OF EVENTS, TRADE SHOWS/SEMINARS/WEBINARS

TOMI Presents the SteraPak at RIA International Restoration Convention & Industry Expo


FREDERICK, Md., April 12, 2022 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® ("TOMI") (NASDAQ: TOMZ), a global company that specializes in disinfection and decontamination through the utilization of its premier Binary Ionization Technology (BIT) platform announced today that the Company is showcasing TOMI's unique technology at the RIA 2022 International Restoration Convention & Industry Expo in Reno, Nevada April 11 ? 13, 2022.

TOMI is attending RIA, "The International Restoration Convention & Industry Expo" to elevate recognition of its technology and brand among large service companies. TOMI welcomes this opportunity to network and partner with leaders in the service industry to demonstrate its technology with the goal of expanding market interest in its products.

While attending the convention and industry expo, TOMI is displaying its latest product ? the SteraPak ? and demonstrating its unique effectiveness and mobility. The SteraPak is the next evolution in the TOMI product line and allows for more industries to implement easy-to-use high log kill disinfection.

"Strategic partnerships are essential to our growth and we're pleased to have this opportunity at RIA to clearly communicate the effectiveness of our product to further establish credibility and service industry connections. We look forward to partnering with large corporations by implementing SteraMist disinfection products into their operations," Elissa Shane, TOMI COO, explained. The RIA tradeshow began Monday, April 11th, and continues through Wednesday, April 13th.

TOMItm Environmental Solutions, Inc.: Innovating for a safer world®?  

TOMItm?Environmental Solutions, Inc. (NASDAQ:TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology®?(BITtm) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BITtm?solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHPtm). Represented by the SteraMist® brand of products, iHPtm produces a germ-killing aerosol that works like a visual non-caustic gas.

TOMI?products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities.?TOMI?products and services have also been used in single-family homes and multi-unit residences.

TOMI?develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, America Seed Trade Association, and The Restoration Industry Association.

For additional information, please visit?http://www.tomimist.com/?or contact us at?[email protected]

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management's judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, statements relating to TOMI's competitive position and manufacturing capabilities. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, the impact of COVID-19 pandemic on our business and customers; our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2021 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today's date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.

INVESTOR RELATIONS CONTACT:

John Nesbett/Jennifer Belodeau

IMS Investor Relations

[email protected]



These press releases may also interest you

at 08:00
INT'L DAY OF PEOPLE WITH DISABILITIES: Salesian Missions highlights social and educational programs that promote inclusion Almost 1 billion people living with a disability, according to the World Health Organization. Salesian Missions, the U.S....

2 déc 2022
JelloX Biotech is celebrating a robust year of research and product development milestones while showcasing the potential for 3D imaging and AI to be the future of cancer pathology....

2 déc 2022
AUO Display Plus (ADP) will participate in the...

2 déc 2022
Bright Minds Biosciences Inc. ("Bright Minds" or the "Company") is pleased to announce that, further to its news release on November 28, 2022, it has closed a non-brokered private placement of (i) 666,000 pre-funded warrants of...

2 déc 2022
New Capital Enables Growing Specialty Partnership Organization to Continue to Scale Endodontic Practice Partners (EPP), a Nashville-based specialty partnership organization, announces the securing of an additional debt facility to expand its growing...

2 déc 2022
On December 1, 2022, Mr. Wilmot Matthews acquired 5,555,556 units ("Units") of SQI Diagnostics Inc. ("SQI" or the "issuer") at a price of $0.09 per Unit or an aggregate purchase price of $500,000.04 pursuant to the closing of a non-brokered private...



News published on 12 april 2022 at 08:30 and distributed by: